Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Why study prions and prion diseases?
- Animal prion diseases
- Human prion diseases
- Acquired human prion diseases
- Characteristics of the prion diseases
- Prions are unique pathogens
- Convergence of evidence for the prion hypothesis
- The prion (protein-only) hypothesis
- Infectious properties of prions - strains
- Prion strains
- PrP conformation and prion strains
- Infectious properties of prions - species barriers
- Prion species barriers
- Transgenic modeling of prion transmission barriers
- Abrogating the species barrier to human prions
- Chronic wasting disease in North American cervids
- Development of transgenic mice for studying CWD
- Mice have a species barrier to CWD prions
- Transgenic mouse models of CWD
- Eliminating the barrier to CWD prion transmission
- Abrogating the species barrier to cwd prions
- Properties of Tg(CerPrP)1536+/- mice
- Assessing tissue distribution of CWD prions
- Bioassay of CWD prions in skeletal muscle
- Prions in skeletal muscles of deer with CWD
- Agent distribution in terminally BSE-diseased cow
- Studies results
- Cervid PRNP polymorphisms and pathogenesis
- Codon 129 genotypes in human prion diseases
- Tg mice expressing L132 CerPrP polymorphisms
- CWD transmission and matching amino acids
- CerPrPSc accumulation in Tg(CerPrP) mice
- CWD-resistant Tg(CerPrP-L132) mice
- Immunoblotting conformation
- Conformational stability assay for strain properties
- Histoblotting for PrP depositions
- Summary
- Acknowledgements
Topics Covered
- Prions represent a new biological paradigm of protein-mediated information transfer
- Prions are the cause of fatal, transmissible neurodegenerative diseases, often referred to as transmissible spongiform encephalopathies (TSEs)
- Many unresolved issues remain including the exact molecular nature of the prion, the detailed mechanism of prion propagation, and the mechanism by which prion diseases can be both genetic and infectious
- The factors governing the transmission of prions between species remain unclear, in particular the means by which prion strains and PrP primary structure interact to affect inter-species prion transmission
- Dramatic advances in our understanding of prions have occurred because of their transmissibility to experimental animals and the development of transgenic (Tg) mouse models has done much to further our understanding about various aspects of prion biology
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Telling, G. (2008, September 4). Transgenic mouse models of prion diseases [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/CNGB5763.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Glenn Telling has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.